This 2024–2029 strategy builds on our experience, to support country-led implementation research that improves access to, and scale-up of, health interventions, strategies and policies and strengthens health systems.
We will work with implementers and social innovators, alongside researchers, to help democratize research and demonstrate that it is a useful and practical tool for people tackling health issues on the ground.
In collaboration with universities and research organizations in low- and middle-income countries, we will meet the growing demand for implementation research training and contribute to a new generation of public health leaders.
The implementation of our new strategy relies heavily on how we partner with stakeholders. As a Special Programme based at WHO headquarters, we will continue to work closely with many WHO departments and the six WHO regional offices. This strong connection helps us to coordinate our work and leverage WHO actions that improve health on the ground.
Relationships with our other co-sponsors at UNICEF, UNDP and the World Bank, and with numerous other global health partners, are also critical to our success, particularly in optimizing our contribution to the Sustainable Development Goals.
Our focus remains firmly on addressing infectious diseases of poverty, and our new strategy is grounded in country-led priorities. However, we recognize that this cannot be done effectively without taking into consideration the changing global context - political, economic, social and environmental (including climate change and loss of biodiversity) – in which we work. We will be proactive in identifying opportunities where our activities can contribute to building country resilience to four major global health challenges.
The Vision is the health and well-being of people burdened by infectious diseases of poverty is improved through the power of research and innovation; and the mission is to support innovative global health research, strengthen in-country health research systems and promote the translation of evidence to improve interventions that reduce the burden of infectious diseases for the most under-served and vulnerable populations